F. Nayeri et al., HEPATOCYTE GROWTH-FACTOR (HGF) IN PATIENTS WITH PNEUMONIA - A COMPARISON BETWEEN SURVIVORS AND NONSURVIVORS, Scandinavian journal of infectious diseases, 30(4), 1998, pp. 405-409
Hepatocyte growth factor (HGF) is a multifunctional growth factor. Aft
er lung injury HGF is secreted in the lung and promotes reconstruction
of the damaged organ. We measured, retrospectively, the serum HGF con
centrations collected on admission in 55 patients with bacterial pneum
onia, using an enzyme-linked immunosorbent assay (ELISA). The patients
were divided into 3 groups: Group 1 was survivors with normal liver f
unction (ir = 14), Group 2 was survivors with abnormal Liver function
(n = 31) and Group 3 was non-survivors (n = 10). Median concentrations
of HGF were elevated in Groups 1 and 2; and no statistically signific
ant difference between these 2 groups was found. Group 3 had a median
HGF concentration within the reference range, significantly lower than
both Group 1 and Group 2. In addition LDH was significantly higher in
pen-survivors as compared with survivors. The combination of LDH and
HGF concentrations discriminated between survivors and non-survivors (
sensitivity 0.90 and specificity 0.96). The results support the hypoth
esis that increased levels of HGF might be a natural part of the heali
ng process of lung injury, irrespective of liver involvement, and that
patients without increased HGF levels, especially those with concomit
ant liver function impairment, may have a poor prognosis.